Intelligence Platform
Patents
Browse 595 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11497713
Combination taxoid nanoemulsion with immunotherapy in cancer
granted patentUS 11497788
Supramolecular glycosaminoglycans
granted patentUS 11491231
Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the as
granted patentUS 11485734
Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2C (5-HT
granted patentUS 11464719
Cosmetic and dermatological compositions
granted patentUS 11453640
Small molecules for disrupting the super elongation complex and inhibiting transcription e
granted patentUS 11446271
Methods and compositions for increasing the potency of antifungal agents
granted patentUS 11439632
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted patentUS 11439635
B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoho
granted patentUS 11439590
Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabr
granted patentUS 11433131
Adoptive cell therapy using spherical nucleic acids (SNAs)
granted patentUS 11413337
Peptide conjugated particles for the treatment of inflammation
granted patentUS 11401387
Photocontrolled dynamic covalent linkers for polymer networks
granted patentUS 11389517
Peptide conjugated particles
granted patentUS 11369622
Methods and compounds to inhibit enveloped virus release
granted patentUS 11371008
Systems for producing cellular immunotherapeutics and methods of use thereof
granted patentUS 11364304
Crosslinked micellar spherical nucleic acids
granted patentUS 11344569
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resist
granted patentUS 11311485
Self-assembled particles for targeted delivery of immunomodulators to treat autoimmunity a
granted patentUS 11304988
Inhibiting tumor cell migration by inhibition of kinesin light chain 1, variant 1 (KLC1C)
granted patentUS 11299496
Ligands for alpha-7 nicotinic acetylcholine receptors and methods of treating neurological
granted patentUS 11298430
Magnetic nanocomposite compositions
granted patentUS 11285106
Synthetic nanostructures including nucleic acids and/or other entities
granted patentUS 11246871
Targeting adenosine A2A receptors for the treatment of levodopa-induced dyskinesias
granted